| CPC A61K 47/54 (2017.08) [A61K 47/543 (2017.08); A61K 48/0008 (2013.01); C07C 227/06 (2013.01); C07C 229/08 (2013.01); C07D 211/28 (2013.01); C07D 211/58 (2013.01); C12N 15/1137 (2013.01); C12N 15/88 (2013.01); C12N 2310/11 (2013.01); C12N 2310/141 (2013.01)] | 21 Claims |
|
1. A compound having the general structure I, or pharmaceutically acceptable salts thereof:
![]() wherein:
each of X1 and X2 is a moiety independently selected from the group consisting of O and NH;
each of Y and Z is C═O;
each of R1 is independently selected from the group consisting of substituted or unsubstituted, branched or unbranched alkyl groups having between 3 and 20 carbon atoms;
each of R2 is independently selected from the group consisting of substituted or unsubstituted, branched or unbranched alkyl groups having between 3 and 20 carbon atoms, or
is hydrogen or absent when m=p=0;
each of R4, R5, R6 and R7 is a moiety independently selected from the group consisting of hydrogen, substituted or unsubstituted, branched or unbranched aliphatic group;
x is 1 or 2;
n is 1 or 3;
m is 0, 1, or 3;
p is an integer independently having the value of 0 or 1;
R3 is selected from:
![]() wherein
each N* indicates the nitrogen atom N in the above structure I to which-(CR4R5)n—Y-X1-R1 and —(CR6R7)m—(Z—X2)p—R2 are attached, and each H on any * position may be replaced with —(CR4R5)n—Y-X1-R1 or —(CR6R7)m—(Z—X2)p—R2 groups to achieve the attachment to the nitrogen atom when the N* is the nitrogen atom N in structure I.
|